TP53 and non-small cell lung carcinoma: Van Egeren D et al.21 have also documented a significant correlation between TP53 gene alterations and new distant metastases (HR = 1.43,95% CI 1.09-2.90) in non-small cell lung cancer in 759 patients with stage I-III disease.